Related Experiment Video
Updated: Jun 22, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Cognitive Impairment in Multiple Sclerosis: Past, Present, and Future.
1Department of Clinical Neurosciences, University of Calgary, Hotchkiss Brain Institute, Calgary, Alberta, Canada; Foothills Medical Centre, 907 South Tower, 1403 29th Street NorthWest, Calgary, Alberta T2N 2T9, Canada.
Cognitive impairment in multiple sclerosis (MS) is common and often overlooked, impacting quality of life. Regular screening for persons with MS (PwMS) using validated tests can improve care and well-being.
Area of Science:
- Neurology
- Neuroscience
- Clinical Medicine
Background:
- Cognitive impairment is a frequent and often underrecognized issue in multiple sclerosis (MS).
- Subtle and insidious clinical presentation leads to underestimation of disability in persons with MS (PwMS).
Purpose of the Study:
- To highlight the underrecognition of cognitive impairment in MS.
- To emphasize the impact of relapses on cognition.
- To advocate for regular cognitive screening in PwMS.
Main Methods:
- Review of recent evidence on cognitive impairment in MS.
- Analysis of the relationship between MS relapses and cognitive function.
Main Results:
- MS relapses can affect cognition similarly to physical symptoms and may be the sole manifestation of a relapse.
- Cognitive impairment is often underdiagnosed in PwMS, leading to an underestimation of overall disability.
Conclusions:
- Regular screening with validated tests is crucial for improving care for PwMS.
- Early identification and management of cognitive impairment can enhance the quality of life for individuals with MS.
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Language and Cognition
Cognitive Development During Adulthood
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

